Interview with Guillaume DRIANNO, General Manager, Servier Brasil
When we met Servier Brazil five years ago the company had major ambitions: ‘grow more than 10% for the five following years’. How have these expectations turned out to be?…
Address: Estrada dos Bandeirantes, 4211
22775-113 – Rio de Janeiro – RJ,Brazil
Tel: (55 21) 2142-1414
Web: http://www.servier.com.br/
Servier Brasil is the first subsidiary of the Servier in Latin America, being present in the country for more than 35 years. In 2001 it opened an International Center of Therapeutic Research in Rio de Janeiro demonstrating a commitment to strengthening their presence in Brazil and Latin America.
Since the opening of its new modern factory in Jacarepaguá, Rio de Janeiro, Servier Brazil has been preparing to become a major supplier of Servier’s innovative drugs to the Brazilian and Latin American market.
Valdoxan, Procoralan 7,5mg, Coversyl, Coversyl Plus, Natrilix SR, Daflon 500, Diamicron MR, Protos, Vastarel, Arcalion , Trivastal Retard, Muphoran, Locabiotal .
When we met Servier Brazil five years ago the company had major ambitions: ‘grow more than 10% for the five following years’. How have these expectations turned out to be?…
Sao Paulo state is responsible for some 85% of pharmaceutical production, and last week Minister Pimentel was in the city of Sao Paulo elaborating on his BrazilMaior plan with strategic…
Besins finally arrived in Brazil in 2010. In addition to introducing the company to the market, would you also elaborate on the strategic motivation behind this decision? Besins Healthcare is…
Much has changed at Bomi since we last met in 2007. At that time, you were launching your new facilities, with 72,000 square metres of built area, 14 metres free…
Two days ago, the Ministry of Health released an article stating that chronic diseases now account for 70% of all deaths in Brazil, and welcoming suggestions for the national plan…
Your position unites two somewhat incongruous titles – Director of Sustainability, and New Business. How did this come to be, and what if any overlap is there between these two…
You came to Boehringer Ingelheim in 2009 – what are some of the most exciting milestones and achievements you have presided over during this time? Looking back on almost three…
What have been some of the recent milestones and achievements contributing to AstraZeneca Brazil’s status as the country’s fastest growing MNC? What happened in the last 10 years was a…
An important topic in Brazil is access to drugs. In recent interviews we have spoken about a third of MS patients being treated, or 10% of hypertensives having their condition…
Yesterday the Ministry of Health released an article stating that chronic diseases now account for 70% of all deaths in Brazil, and welcoming suggestions for the national plan against chronic…
10 days ago, your Swedish counterpart Mats Larsson made a technical visit here at ANVISA and said he had a lot to learn. What is it about ANVISA that can…
Yesterday, Minister Pimentel unveiled the Brazil Maior plan to increase competitiveness and growth across a variety of industrial sectors. If you had to give recommendations to improve the Brazilian pharmaceutical…
When we met Servier Brazil five years ago the company had major ambitions: ‘grow more than 10% for the five following years’. How have these expectations turned out to be?…
See our Cookie Privacy Policy Here